Rationale for the Pediatric Hematology and Transfusion Medicine Multidisciplinary Research Training Award (PHTMMRT) at Children?s National

国家儿童医院儿科血液学和输血医学多学科研究培训奖 (PHTMMRT) 的理由

基本信息

  • 批准号:
    10360585
  • 负责人:
  • 金额:
    $ 12.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-02-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

The rationale for this renewal application is to continue our highly collaborative and multidisciplinary, inter- institutional program of mentored training for future scientists in pediatric transfusion medicine and hematology. Our objective is to address the barriers for the conduct of high quality and transformative research in pediatric transfusion medicine and hematology including: 1) lack of a robust infrastructure for research training and implementation; 2) shortage of mid-career and senior investigators to serve as research mentors; 3) need for multidisciplinary translational approaches to answer critical clinical questions; 4) lack of diversity among clinical and translational investigators. This program is focused on advancing clinical and translational scholarship on the diagnosis and clinical management of hematological, cardiovascular and pulmonary disorders, transfusion, cell therapy and transplantation. The design of the Pediatric Hematology and Transfusion Medicine Multidisciplinary Research Training Award (PHTMMRT) is focused on preparing trainees from diverse backgrounds for academic leadership and independently funded research careers. Each trainee in the program completes a Master's in Clinical and Translational Science (MsCTR) at the George Washington University (GWU) School of Medicine and Health Sciences or equivalent, and will devise, implement and complete a research project under the joint oversight of a multidisciplinary mentorship team. At the completion of the two- to three-year program, each trainee will have presented his/her data to at least one national research meeting, drafted and submitted one or more manuscripts suitable for external peer-reviewed publications, and for those in a three-year program, submitted an external grant application to the NIH or equivalent funding source. The program is overseen by two NIH-funded Principal Investigators with complementary clinical and research expertise, supported by nine faculty of Children's National and GWU, with four external mentors. All mentors are research scientists with expertise in coagulation, transfusion medicine, cell therapy, transplantation, vascular biology and genomic/proteomics. A Diversity Enhancement Officer will assist in the recruitment of minority, disabled or disadvantaged applicants, and women. Finally, an External Advisory Committee of four NIH-funded national leaders in transfusion medicine, transplantation and hematology with established career mentorship programs will offer annual feedback and guidance of the PHTMMRT program and the trainees' progress. The PHTMMRT program will leverage several of Children's National's multiple and pre-existing strengths with collaborating neighboring research institutions including the NIH, GWU and Howard University School of Medicine (HUSM). In summary, our multidisciplinary, inter-institutional mentors will train four to five future academic leaders in Pediatric Hematology/Transfusion Medicine including a focus on cell-based therapies for heart, lung and blood diseases.
这一更新申请的理由是继续我们的高度合作和多学科,跨- 为儿科输血医学和血液学未来科学家提供指导培训的机构计划。 我们的目标是解决在儿科进行高质量和变革性研究的障碍 输血医学和血液学包括:1)缺乏强大的研究培训基础设施, 2)缺乏担任研究导师的中级和高级调查员; 3)需要 多学科翻译方法来回答关键的临床问题; 4)临床之间缺乏多样性 和翻译研究人员。该计划的重点是推进临床和翻译奖学金, 血液、心血管和肺部疾病的诊断和临床管理,输血, 细胞疗法和移植。《儿科血液学与输血学》课程设计 多学科研究培训奖(PHTMMRT)的重点是准备学员从不同的 学术领导和独立资助的研究事业的背景。项目中的每个学员 在乔治华盛顿大学完成临床和转化科学(MsCTR)硕士学位 (GWU)医学与健康科学学院或同等学历,并将设计、实施和完成 在多学科指导小组的联合监督下开展研究项目。在完成两个- 到三年计划,每个受训者将至少向一次国家研究会议提交他/她的数据, 起草并提交了一份或多份适合外部同行评审出版物的手稿, 在一个为期三年的项目中,向NIH或同等资金来源提交了外部赠款申请。的 该项目由两名NIH资助的主要研究者监督,他们具有互补的临床和研究 专业知识,由儿童的国家和GWU的九个教师的支持,与四个外部导师。所有导师 是研究科学家,在凝血,输血医学,细胞治疗,移植, 血管生物学和基因组学/蛋白质组学。多样性促进干事将协助征聘 少数族裔、残疾人或弱势群体申请人以及妇女。最后,一个由四人组成的外部咨询委员会 NIH资助的输血医学,移植和血液学领域的国家领导人,具有既定的职业生涯 导师计划将提供PHTMMRT计划的年度反馈和指导, 中求进工作总PHTMMRT计划将利用儿童国家的多个和预先存在的几个 与包括NIH、GWU和霍华德大学在内的邻近研究机构合作的优势 医学院(HUSM)。总之,我们的多学科,跨机构的导师将培训四到五个 儿科血液学/输血医学的未来学术领导者,包括专注于基于细胞的 治疗心脏、肺和血液疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Catherine M. Bollard其他文献

Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
  • DOI:
    10.1016/j.bbmt.2014.11.299
  • 发表时间:
    2015-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jessica Hochberg;Renuka P. Miller;Patrick J. Hanley;Sarah McCormack;Lauren Harrison;Olga Militano;Phyllis Brand;Catherine M. Bollard;Mitchell S. Cairo
  • 通讯作者:
    Mitchell S. Cairo
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May Be Protective In Vivo
  • DOI:
    10.1016/j.bbmt.2014.11.049
  • 发表时间:
    2015-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Patrick J. Hanley;Jan Melenhorst;Sarah Nikiforow;Phillip Scheinberg;Russell Cruz;Robert A. Krance;Kathryn Leung;Caridad Martinez;Helen E. Heslop;Cliona M. Rooney;A. John Barrett;Elizabeth J. Shpall;Catherine M. Bollard
  • 通讯作者:
    Catherine M. Bollard
A Phase 1 Dose Escalation and Expansion Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Co-Stimulation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE-1)
  • DOI:
    10.1182/blood-2024-201138
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Robert Weinkove;Philip George;Robert Fyfe;Aine Hurley;Nathaniel Dasyam;Yasmin Nouri;Tess Ostapowicz;Stefan Mullins;Giulia Giunti;Brittany Lavender;Brigitta Mester;Catherine M. Bollard;Travis Perera;Hayden Jina;Alwyn D'Souza;Le Qin;David S. Ritchie;Chris M.A. Frampton;Rachel Perret;Peng Li
  • 通讯作者:
    Peng Li
Refined/Accelerated T Cell Therapies for the Treatment of EBV+ Lymphomas
  • DOI:
    10.1016/j.bbmt.2013.12.206
  • 发表时间:
    2014-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Serena Kimi Perna;Minthran Ngo;Natalia Lapteva;Jun Ando;Lisa Rollins;Oumar Diouf;Ann M. Leen;Juan F. Vera;Vicky Torrano;Adrian P. Gee;Stephen Gottschalk;Carlos A. Ramos;Catherine M. Bollard;Helen E. Heslop;Cliona M. Rooney
  • 通讯作者:
    Cliona M. Rooney
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
  • DOI:
    10.1016/j.bbmt.2012.11.098
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sawa Ito;Nancy Hensel;Minoo Battiwalla;Jan Melenhorst;Pawel Muranski;Samantha Miner;Kazushi Tanimoto;Fang Yin;Keyvan Keyvanfar;Libby Koklanaris;Jeanine Superata;Jan Haggerty;Catherine M. Bollard;A. John Barrett
  • 通讯作者:
    A. John Barrett

Catherine M. Bollard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Catherine M. Bollard', 18)}}的其他基金

NextGen - CRI
下一代 - CRI
  • 批准号:
    10845777
  • 财政年份:
    2022
  • 资助金额:
    $ 12.39万
  • 项目类别:
Cancer Immunotherapy Winter School (CIWS)
癌症免疫治疗冬季学校(CIWS)
  • 批准号:
    10391811
  • 财政年份:
    2022
  • 资助金额:
    $ 12.39万
  • 项目类别:
NextGen - CRI
下一代 - CRI
  • 批准号:
    10627010
  • 财政年份:
    2022
  • 资助金额:
    $ 12.39万
  • 项目类别:
Antigen Specific T Cells
抗原特异性 T 细胞
  • 批准号:
    10197003
  • 财政年份:
    2019
  • 资助金额:
    $ 12.39万
  • 项目类别:
Antigen Specific T Cells
抗原特异性 T 细胞
  • 批准号:
    10671624
  • 财政年份:
    2019
  • 资助金额:
    $ 12.39万
  • 项目类别:
Enhancing cell therapy for brain tumors
增强脑肿瘤的细胞治疗
  • 批准号:
    9788348
  • 财政年份:
    2018
  • 资助金额:
    $ 12.39万
  • 项目类别:
Enhancing cell therapy for brain tumors
增强脑肿瘤的细胞治疗
  • 批准号:
    10477394
  • 财政年份:
    2018
  • 资助金额:
    $ 12.39万
  • 项目类别:
Enhancing cell therapy for brain tumors
增强脑肿瘤的细胞治疗
  • 批准号:
    10246936
  • 财政年份:
    2018
  • 资助金额:
    $ 12.39万
  • 项目类别:
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
HIV 特异性体外扩增 T 细胞疗法 (HXTC) 可消除持续性 HIV 感染的潜在储库
  • 批准号:
    9889986
  • 财政年份:
    2016
  • 资助金额:
    $ 12.39万
  • 项目类别:
Rationale for the Pediatric Hematology and Transfusion Medicine Multidisciplinary Research Training Award (PHTMMRT) at Children?s National
国家儿童医院儿科血液学和输血医学多学科研究培训奖 (PHTMMRT) 的理由
  • 批准号:
    9417175
  • 财政年份:
    2012
  • 资助金额:
    $ 12.39万
  • 项目类别:

相似海外基金

Conference: Bridging Child Language Research to Practice for Language Revitalization
会议:将儿童语言研究与语言复兴实践联系起来
  • 批准号:
    2331639
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Standard Grant
Advancing Child and Youth-led Climate Change Education with Country
与国家一起推进儿童和青少年主导的气候变化教育
  • 批准号:
    DP240100968
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Discovery Projects
Transforming child mental health: co-designing, building and evaluating a digitally enabled, personalised, prevention pathway
改变儿童心理健康:共同设计、构建和评估数字化、个性化的预防途径
  • 批准号:
    MR/X034917/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Fellowship
Improving Legal Frameworks to Support Online Child Sex Abuse Prosecutions
完善法律框架以支持在线儿童性虐待起诉
  • 批准号:
    DP240101649
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Discovery Projects
Building capacity, fostering community, and supporting champions to implement meaningful family engagement in child health research and practice: Development and evaluation of the Family Engagement in Research Champions Community of Practice (FER Champion
建设能力、培育社区并支持倡导者在儿童健康研究和实践中实施有意义的家庭参与:制定和评估家庭参与研究倡导者实践社区(FER Champion
  • 批准号:
    484903
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Salary Programs
Economic analysis of child maltreatment and child protection
虐待儿童与儿童保护的经济分析
  • 批准号:
    DP240101989
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Discovery Projects
CAREER: The role of picture books in promoting parent-child scientific conversation and learning
职业:图画书在促进亲子科学对话和学习中的作用
  • 批准号:
    2339516
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Continuing Grant
Conference: Child Language Acquisition Symposium for Indigenous Communities
会议:土著社区儿童语言习得研讨会
  • 批准号:
    2410232
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Standard Grant
Developing an educational intervention for parents to promote preschool child safety in Nepal
为尼泊尔家长制定教育干预措施以促进学前儿童安全
  • 批准号:
    MR/Z503903/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Research Grant
Examining the role of gender norms in perpetuating the cycle of poverty through Child Labor
审视性别规范在童工导致的贫困循环中的作用
  • 批准号:
    24K21028
  • 财政年份:
    2024
  • 资助金额:
    $ 12.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了